Cellectar Biosciences, Inc. (CLRB) vs IN8bio, Inc. (INAB)
A side-by-side comparison of Cellectar Biosciences, Inc. and IN8bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.56HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
INAB
IN8bio, Inc.
$1.39HealthcareDelayed quote: Oct 6, 2026, 3:28 PM EDT
Total return — CLRB vs INAB
growth of $100 · dividends reinvested · last 5yCLRB -99.3% (-62.6%/yr)INAB -99.5% (-65.7%/yr)CLRB compounded faster over this window
CLRB INAB
CLRB vs INAB: by the numbers
- •INAB is the larger company ($13M vs $12M market cap).
Metrics side by side
Valuation
| Metric | CLRB | INAB |
|---|---|---|
| P/B ratio | 0.42 | 0.73 |
Profitability
| Metric | CLRB | INAB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -74.73% | -101.66% |
| ROIC | -74.94% | -91.74% |
Growth (annualized)
| Metric | CLRB | INAB |
|---|---|---|
| Total return CAGR (5Y) | -60.51% | -62.88% |
Frequently asked
- How have CLRB and INAB total returns compared?
- Over the past 5 years, CLRB delivered -60.51% and INAB delivered -62.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.